Barclays sets USD 105 target and upgrades LivaNova stock
Published on 10/18/2026 at 13:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst and earnings context
- Barclays upgraded LivaNova to Strong Buy on October 8, 2026, after setting a USD 105.00 target.
- LivaNova reported USD 390.59 million in second-quarter 2026 revenue.
- LivaNova will release third-quarter 2026 results on November 4, 2026.
LivaNova (ISIN GB00BYMT0J19) is the subject of a fresh Barclays upgrade to Strong Buy, while the bank's USD 105.00 target puts analyst expectations above the stock's 52-week high of USD 85.76. MarketBeat reported the rating change on October 8, 2026, while Markets Insider reported Barclays' October 6 initiation with the USD 105.00 target.
Second-quarter figures support the case
LivaNova's second-quarter 2026 revenue reached USD 390.59 million, up 10.80 percent from the prior-year quarter, according to MarketBeat. Reported earnings per share were USD 1.26 against a USD 1.09 consensus estimate, a USD 0.17 beat. The finance statement for the quarter ended June 30, 2026, also shows consolidated net income of USD 108.68 million.
The second-quarter update raised LivaNova's full-year 2026 revenue-growth outlook to 8 percent to 9 percent from 7 percent to 8 percent. The company also guided to adjusted diluted earnings per share of USD 4.30 to USD 4.40 for 2026, according to the earnings-call transcript published by Yahoo Finance.
Three dated LivaNova milestones
On August 5, 2026, LivaNova reported second-quarter revenue of USD 390.59 million and raised its 2026 revenue-growth outlook to 8 percent to 9 percent. On September 23, 2026, LivaNova announced a November 4, 2026 release date for third-quarter results. On October 8, 2026, Barclays' rating on LivaNova was reported as Strong Buy, with the analyst consensus target cited at USD 87.75.
What does the target mean for valuation?
The USD 105.00 Barclays target exceeds LivaNova's USD 85.76 52-week high by USD 19.24. The company's market capitalization stood at USD 4.3 billion on October 16, 2026, while its 52-week range was USD 48.82 to USD 85.76. That combination frames the analyst view against a stock that has already moved well above its yearly low.
Next reporting date
LivaNova is scheduled to release third-quarter 2026 results before its conference call on November 4, 2026, according to the company's September 23, 2026 release. The call is scheduled for 1:00 p.m. GMT, or 8:00 a.m. Eastern Time.
Stock context for investors
LivaNova combines a raised 2026 operating outlook with a near-term reporting date and a new Barclays rating. The next results will provide the first scheduled test of the 8 percent to 9 percent revenue-growth outlook.
The further course of trading is shown by the continuously updated real-time quote of LivaNova stock.
LivaNova stock facts
- Company: LivaNova PLC
- ISIN: GB00BYMT0J19
- Ticker: LIVN
- Primary exchange: Nasdaq
- Sector / Industry: Healthcare / Medical devices
- Market capitalization: USD 4.3 billion (as of October 16, 2026)
- 52-week range: USD 48.82-85.76 (as of October 16, 2026)
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
